Merck & (MRK) Revenue — Quarter Ended Sep 30, 2023
Revenue for the quarter increased compared to the prior period. The company reported higher revenue than both the immediately preceding quarter and the same quarter one year ago.
Key takeaway
Quarter ended Sep 30, 2023 · FY2023 Q3
Revenue for the quarter increased compared to the prior period. The company reported higher revenue than both the immediately preceding quarter and the same quarter one year ago.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$16B
Revenue reported for this quarter.
Quarter-over-quarter
+6.2%
Change from the immediately preceding quarter.
Year-over-year
+6.7%
Change from the comparable year-ago quarter.
Trailing four quarters
$59.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $13.8B | +2.3% |
| Mar 31, 2023 | $14.5B | -8.9% |
| Jun 30, 2023 | $15B | +3.0% |
| Sep 30, 2023 | $16B | +6.7% |
Revenue performance
The reported revenue reflects a positive trend, with growth both sequentially and year-over-year. The magnitude of the increase was similar for both comparisons.
Quarterly comparison
Revenue rose from the preceding quarter and from the same quarter a year earlier, with each increase in the single-digit percentage range. The sequential growth rate and the year-over-year growth rate were both moderate.
What to watch
The company's operating cash flow for the first nine months was reduced by a Zetia antitrust settlement and milestone payments, as noted in the filing.